IL126489A0 - Method for the prevention and treatment of mastitis - Google Patents

Method for the prevention and treatment of mastitis

Info

Publication number
IL126489A0
IL126489A0 IL12648997A IL12648997A IL126489A0 IL 126489 A0 IL126489 A0 IL 126489A0 IL 12648997 A IL12648997 A IL 12648997A IL 12648997 A IL12648997 A IL 12648997A IL 126489 A0 IL126489 A0 IL 126489A0
Authority
IL
Israel
Prior art keywords
micrococcin
mastitis
infection
antibiotics
prevention
Prior art date
Application number
IL12648997A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL126489A0 publication Critical patent/IL126489A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/05—Treating milk before coagulation; Separating whey from curd
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
IL12648997A 1996-06-20 1997-06-19 Method for the prevention and treatment of mastitis IL126489A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810415 1996-06-20
PCT/EP1997/003212 WO1997048408A2 (en) 1996-06-20 1997-06-19 Method for the prevention and treatment of mastitis

Publications (1)

Publication Number Publication Date
IL126489A0 true IL126489A0 (en) 1999-08-17

Family

ID=8225635

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12648997A IL126489A0 (en) 1996-06-20 1997-06-19 Method for the prevention and treatment of mastitis

Country Status (14)

Country Link
US (1) US6187800B1 (enExample)
EP (1) EP0934075B1 (enExample)
JP (1) JP2000513348A (enExample)
CN (1) CN1119170C (enExample)
AT (1) ATE215378T1 (enExample)
AU (1) AU720243B2 (enExample)
BR (1) BR9709812A (enExample)
CA (1) CA2251779A1 (enExample)
DE (1) DE69711661T2 (enExample)
DK (1) DK0934075T3 (enExample)
ES (1) ES2175425T3 (enExample)
IL (1) IL126489A0 (enExample)
PT (1) PT934075E (enExample)
WO (1) WO1997048408A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6638902B2 (en) * 2001-02-01 2003-10-28 Ecolab Inc. Stable solid enzyme compositions and methods employing them
EP1369425A1 (en) * 2001-03-13 2003-12-10 Yamanouchi Pharmaceutical Co. Ltd. Thiopeptide compounds
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
WO2004002451A1 (fr) * 2002-06-28 2004-01-08 Fang Chen Suppositoire a liberation controlee utilise dans un canal secreteur de lait
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ539076A (en) * 2005-03-29 2008-05-30 Blis Technologies Ltd Skin treatment compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
CN100448480C (zh) * 2005-11-09 2009-01-07 北京大北农科技集团股份有限公司 治疗奶牛乳房炎的乳房用无菌粉针制剂及其制备方法
CN101547698B (zh) * 2006-10-10 2014-01-08 威斯康星旧生研究基金会 乳房内乳头密封剂和使用该制剂降低或消除成熟干酪中视觉缺陷的方法
JP5773983B2 (ja) 2009-04-08 2015-09-02 ウィスコンシン アルムニ リサーチ ファンデイション 乳房内乳頭シール剤及びその熟成チーズの外観上の欠陥を減少又は除去のための使用
WO2011046853A1 (en) * 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
EP2361632B1 (en) * 2010-02-19 2014-03-19 Protectimmun GmbH Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
RU2662300C2 (ru) * 2013-02-08 2018-07-25 Луода Фарма Пти Лимитед Способы лечения микробных инфекций, в том числе мастита
EP2953623B1 (en) * 2013-02-08 2021-06-30 Luoda Pharma Limited Methods of treating topical microbial infections
TW201607534A (zh) * 2013-10-31 2016-03-01 皮拉馬爾企業有限公司 治療困難梭狀芽孢桿菌相關感染用硫肽化合物
BR112019012804A2 (pt) * 2016-12-27 2020-03-17 Colgate-Palmolive Company Composição antitranspirante/desodorante
GB202014427D0 (en) * 2020-09-14 2020-10-28 Norwegian Univ Of Life Sciences Composition and use
EP4342484A4 (en) * 2021-05-21 2025-04-16 A&J Science Co.,Ltd. Pharmaceutical composition comprising macrocosine compound and method for preparing macrocosine compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169847C (en) * 1993-08-20 2006-02-14 John Edmondson Peel Method for the prevention and treatment of bovine mastitis

Also Published As

Publication number Publication date
JP2000513348A (ja) 2000-10-10
AU3341097A (en) 1998-01-07
EP0934075B1 (en) 2002-04-03
PT934075E (pt) 2002-08-30
ES2175425T3 (es) 2002-11-16
EP0934075A2 (en) 1999-08-11
DE69711661D1 (de) 2002-05-08
ATE215378T1 (de) 2002-04-15
CN1222081A (zh) 1999-07-07
DE69711661T2 (de) 2002-10-17
BR9709812A (pt) 1999-08-10
AU720243B2 (en) 2000-05-25
DK0934075T3 (da) 2002-06-10
CN1119170C (zh) 2003-08-27
CA2251779A1 (en) 1997-12-24
US6187800B1 (en) 2001-02-13
WO1997048408A3 (en) 1998-02-19
WO1997048408A2 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
IL126489A0 (en) Method for the prevention and treatment of mastitis
Owens et al. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation
ATE277638T1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
MY118641A (en) Method of preventing, countering or reducing chronic gastrointestinal disorders or nsaid-induced gastrointestinal damage
MY113059A (en) Controlled-release dosage forms of azithromycin
SE9901647L (sv) Anordning för behandling av spenar
AU6289196A (en) A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
Nagahata et al. Effects of intramammary infusion of Bifidobacterium breve on mastitis pathogens and somatic cell response in quarters from dairy cows with chronic subclinical mastitis
Oliver et al. Antibiotic residues and prevalence of mastitis pathogen isolation in heifers during early lactation following prepartum antibiotic therapy
EP0301785A3 (en) Carboxamide derivatives of glycopeptides
GR3036573T3 (en) Method for the prevention and treatment of bovine mastitis
SE9301994D0 (sv) Framstaellning av steril mjoelk
Hogan et al. Efficacy of dry cow therapy and a Propionibacterium acnes product in herds with low somatic cell count
Todhunter et al. In vitro growth of mastitis associated streptococci in bovine mammary secretions
NZ509605A (en) Cheese ripening process using an attenuated bacterial starter culture obtained by treatment with a surface active agent
Janosi et al. The use of the dry cow therapy in the control of bovine mastitis
ATE279939T1 (de) Phytase zur vorbeugung oder behandlung von mastitis
WO2004071324A3 (en) Method to reduce, eliminate, or prevent bacterial pathogen colonization in eggs and/or poultry using bacteriophages
NZ503145A (en) 8a-Azalides as veterinary antimicrobial agents to treat bacterial respiratory infection
Owens et al. Therapeutic and prophylactic effect of prepartum antibiotic infusion in heifers
US20060019926A1 (en) Methods for prevention and treatment of mastitis
Hogan et al. Efficacy of parenteral vitamin E for treating bovine mastitis.
Hogan et al. Efficacy of Dry Cow Therapy and a Propionibacterium acnes Product in Low Somatic Cell Count Herds
WO2024192151A3 (en) Method of dosing vapendavir to treat enterovirus infections
WO1999000140A3 (en) Accelerating animal hoof growth with somatotropin